Evidence map›Paper›PMID 41446807›Full record

ReviewComputational and structural biotechnology journal2025

Drug response in the era of precision medicine: A methodological review.

Daniella Okyere, Laura Bravo-Merodio, Yuanwei Xu, Xin Guan, Durga Parkhi, Georgios Gkoutos, Animesh Acharjee

Abstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Artemis: Harnessing Knowledge Graphs for Next-Generation Drug Target Prioritization.Computational and structural biotechnology journal · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniella OkyereCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Laura Bravo-MerodioCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Yuanwei XuCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Xin GuanCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Durga ParkhiCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Georgios GkoutosCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Animesh AcharjeeCancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing availability of structured data types, including molecular and pharmacological data, along with unstructured data types such as medical imaging data, has enabled the development of statistical, machine learning (ML), and deep learning (DL) approaches for drug response prediction. These computational methods are integral to precision medicine, leveraging data-driven techniques to predict patient-specific treatment outcomes. This review provides a systematic overview of existing methodologies for drug response prediction, focusing on input data structures, response variable definitions, and data types utilized. In contrast to previous reviews that focus on specific therapies or computational approaches, we present a unified classification framework based on data-response relationships, including single data type with a response vector, single data type with a response matrix, and multiple data types with a response. By using this structure, we can compare statistical and ML-based models across different diseases and data types. Finally, we discuss evaluation strategies, highlight emerging methodological trends, and outline key challenges and future opportunities to advance drug response prediction.

Indexed as

Drug responsemachine learning, multomics

Identifiers

PMID41446807
PMCPMC12722026

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.